Immunotherapy is a type of cancer treatment that enhances the body’s natural defenses to fight the cancerous tissues. In this therapy substances made by the body or in a laboratory are used to improve or restore immune system function.There are several types of immunotherapy such as Monoclonal antibodies, Non-specific immunotherapies,Oncolytic virus therapy, T-cell therapy and Cancer vaccines.The drug used for this therapy is called Immunotherapy Drugs. Immunotherapy drugs are designed to alert the immune system about mutated cells so it can find and destroy them easily. Such as, Ipilimumab, Atizolizumab, Avelumab, Pembrolizumab and Nivolumab. Some Side effects of Immunotherapy are Fatigue, Fever, Chills, Weakness, Nausea, Vomiting, Dizziness, High or Low Blood Pressure, Headache, Diarrhea and Cough.
Market Dynamics –
Rising adoption of targeted therapies with fewer side effects, quicker drug approval processes and highest prevalence rate of lifestyle diseases such as atherosclerosis, heart disease, stroke, obesity, type 2 diabetes and diseases associated with smoking and alcohol and drug abuse is anticipated to fuel the immunotherapy drugs market growth. Moreover, Materialization of biosimilars is another driving factor for the immunotherapy drugs market.However, the high cost of immunotherapy treatment such as Current checkpoint inhibitors each have a price approximate $150,000 a year. A combination of Yervoy and Opdivo approved by FDA(Food and Drug Administration) for advanced or impossible tumor has a cost of $256,000 per one year for patients who respond to the treatment. Thus high cost of drug can affect the growth of immunotherapy drug market. Nonetheless, growing opportunities in the emerging markets and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy.
Regional Analysis –
North America is probable to attain the largest share of the Immunotherapy Drug Market in terms of revenue and expected to hold the position followed by Europe region.This is due to favorable government initiatives, increased expenditure on Research and Development, personalized medicineand availability of technologically advanced health care research framework. Asia Pacific is likely to achieve a high growth rate of the immunotherapy drugs market in the next few years due to development of health care infrastructure, high disposable income, rise in health and hygiene related awareness, large untapped market base, and economic development.Prosperous middle class willing to spend on quality healthcare products is driving the Immunotherapy drug Market.Furthermore, increased awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.
Top Immunotherapy Drug Keyplayers –
Hoffmann-La Roche AG is a Swiss multinational healthcare company established in 1896 and headquartered in Switzerland. Specialties in biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data, and Science.
GlaxoSmithKline plc is a British multinational pharmaceutical company established in 1830 and headquartered in Brentford, Middlesex. Specialties in Pharmaceutical products, Vaccines, and Consumer healthcare products.
Amgen Inc. is an American multinational biopharmaceutical company established in 1980 and headquartered in Thousand Oaks, CA. Specialties in Biologics, Human therapeutics, and Development of novel products.
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme is an American multinational pharmaceutical company established in 1981 and headquartered in Kenilworth, NJ. Specialties in Pharmaceutical.
Bristol Myers Squibb is an American pharmaceutical company established in 1845 and headquartered in Lawrence Township, NJ. Specialties in biotechnology, innovation, pharmaceuticals, research and development, and healthcare.
Novartis International AG is a Swiss multinational pharmaceutical company established in 1996 and headquartered in Basel, Baselstadt. Specialties in Research, Innovation, Quality, Sustainability, innovative medicines, generic medicines and biosimilars, global leader in eye care, unique portfolio focuses & broad healthcare portfolio, Cell & Gene Therapy, and Data & Digital.
Johnson & Johnson is an American multinational corporation established in 1886 and headquartered in New Brunswick, NJ. Specialties in Health Care, Medical Devices & Diagnostics, Pharmaceuticals, and Consumer.
AstraZeneca plc is a British multinational pharmaceutical and biopharmaceutical company established in 1999 and headquartered in Cambridge, Cambridgeshire. Specialties in Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business.
OPKO Health is a medical test and medication company established in 1991 and headquartered in Miami, FL. Specialties in Pharmaceutical and Diagnostic Products, Medical Devices, and life sciences.
Myriad Genetics, Inc. is an American molecular diagnostic company established in 1991 and headquartered in Salt Lake City, UT. Specialties in Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Rheumatoid Arthritis, Hereditary Cancer, Prostate Cancer, Breast Cancer, Melanoma, Prenatal Screen, and Precision Medicine.
Key Benefits –
Immunotherapy Drug Market report covers in depth historical and forecast analysis.
Immunotherapy Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Immunotherapy Drug Marketreport helps to identify opportunities in market place.
Immunotherapy Drug Market report covers extensive analysis of emerging trends and competitive landscape.